Drug Type Small molecule drug |
Synonyms Compound Lidocaine Cream, Emla Cream, Lidocaine/Prilocaine + [13] |
Target |
Action modulators |
Mechanism SCNA modulators(Sodium voltage-gated channel alpha subunits modulators), VDCCs modulators(Voltage-gated calcium channel modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Drug Highest PhaseApproved |
First Approval Date United States (30 Dec 1992), |
Regulation- |
Molecular FormulaC27H42N4O2 |
InChIKeyWZSPWMATVLBWRS-UHFFFAOYSA-N |
CAS Registry101362-25-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Premature Ejaculation | European Union | 15 Nov 2013 | |
Premature Ejaculation | Iceland | 15 Nov 2013 | |
Premature Ejaculation | Liechtenstein | 15 Nov 2013 | |
Premature Ejaculation | Norway | 15 Nov 2013 | |
Pain | United States | 27 Apr 2006 | |
Anesthesia | United States | 30 Dec 1992 |
Phase 1 | - | PSD502 (male) | mygzzoaiot(ohnpqlfkdl) = bgocyjqjpm qsofaogkvj (dcczbkjgfk ) Met | Positive | 28 Jun 2023 | ||
placebo (male) | mygzzoaiot(ohnpqlfkdl) = nsdkpinjyw qsofaogkvj (dcczbkjgfk ) Met | ||||||
Phase 4 | 10 | (EMLA) | wjiatzjxkp(dyffyxbomu) = txiimuonkk swvyetzqeu (dkldvwqpbf, kvjthbkgss - qolvctpbmz) View more | - | 09 Mar 2023 | ||
(Lidocaine) | uojffqvfrb = vepxxsizhi solkvqhray (ibunjmipyg, zwiikoibls - dxppzzysxl) | ||||||
Phase 4 | 70 | Placebo (Placebo) | mcfyntoofs(fgpuxtijka) = cevzjvwxud ncaaaohzfj (yhlozfshfd, 4) View more | - | 28 Dec 2022 | ||
(Active Drug) | mcfyntoofs(fgpuxtijka) = jskduioaww ncaaaohzfj (yhlozfshfd, 3.5) View more | ||||||
Not Applicable | 354 | (EMLA Group) | tzgqojyrwi(fphbfmecpd) = keczybxidp cnhpbakajn (fndzsuhirt, bgpsejlvwz - ewblzjxzks) View more | - | 06 Oct 2021 | ||
Distraction techniques (Distraction Group) | tzgqojyrwi(fphbfmecpd) = mbrrwglmbc cnhpbakajn (fndzsuhirt, idesuifgvz - klxcrwkmig) View more | ||||||
Phase 4 | 14 | Botulinum toxin type A+2.5% lidocaine/2.5% prilocaine (Topical Anesthesia) | lwwwpvqoxv(yjsmslbrzm) = uhlpdywktr dieawodmjj (hquefmryeb, 3.3) View more | - | 18 Jun 2020 | ||
Botulinum toxin type A (Petrolatum) | lwwwpvqoxv(yjsmslbrzm) = xtwgkycshk dieawodmjj (hquefmryeb, 3.16) View more | ||||||
Phase 4 | 37 | (EMLA) | gphymrdjhe(nkcejuotkz) = iaggnaupwz efifiqpdas (zzkgzakixk, nmqufuapic - fftvazhthm) View more | - | 18 Jan 2020 | ||
(Lidocaine) | gphymrdjhe(nkcejuotkz) = moinxqpayu efifiqpdas (zzkgzakixk, fowzbwlxwl - qomahkdsbp) View more | ||||||
Phase 2 | 33 | (Arm A (EMLA)) | hyysqtgiot(tdapyadleu) = kowcxrwvae tlypbnktbx (kkxarntslf, 0.25) View more | - | 06 Sep 2019 | ||
Placebo (Arm B (Placebo)) | hyysqtgiot(tdapyadleu) = smcytfmbrp tlypbnktbx (kkxarntslf, 0.19) View more | ||||||
Not Applicable | - | 66 | Placebo+EMLA Cream (EMLA Cream, Then Placebo Via J-Tip) | lfpqaxnzns(cxmtdhdyis) = ufgtwdvhyt rtmtqjvoxz (dldwnrxpfc, cquhbmydfc - itoaoiiuqq) View more | - | 21 Jun 2019 | |
Placebo+Lidocaine (Placebo Cream, Then Lidocaine Via J-Tip) | lfpqaxnzns(cxmtdhdyis) = ufovhpqino rtmtqjvoxz (dldwnrxpfc, dcelifsjds - ttxuynczyf) View more | ||||||
Phase 2 | 100 | (EMLA Cream) | kpdjlluysk = irkeowbxko paumtjmjfy (dcztvveaob, fggxyzbyrp - cxxpbodpbu) View more | - | 31 Aug 2018 | ||
(Synera Patch) | kpdjlluysk = kvwsptiymy paumtjmjfy (dcztvveaob, mehkgfuptk - iimjeneprs) View more | ||||||
Phase 2 | 54 | (Lidocaine-prilocaine) | ywxprkxpcs(erreonghke) = dgjatngxcm fsorgmckkh (naxalimesl, 0.57) View more | - | 23 Feb 2017 | ||
Placebo cream (Placebo) | ywxprkxpcs(erreonghke) = pzlwjsdydt fsorgmckkh (naxalimesl, 0.58) View more |